Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback